Rheumatoid Arthritis: ABO21009 Treatment Study

We are testing a new treatment called ABO21009 in healthy volunteers and patients with rheumatoid arthritis. The goal is to see how it compares to a placebo in terms of safety and effects.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre hospitalier universitaire de Liege
rheumatology
Tilff, Belgium
Centre for Human Drug Research
Immunology
Oegstgeest, Netherlands
Sponsor: Aboleris Holdco
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.